BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25623859)

  • 1. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.
    Chao CN; Huang YL; Lin MC; Fang CY; Shen CH; Chen PL; Wang M; Chang D; Tseng CE
    J Transl Med; 2015 Jan; 13():29. PubMed ID: 25623859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like Particles.
    Chao CN; Lin MC; Fang CY; Chen PL; Chang D; Shen CH; Wang M
    PLoS One; 2016; 11(6):e0157865. PubMed ID: 27322500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector.
    Chao CN; Yang YH; Wu MS; Chou MC; Fang CY; Lin MC; Tai CK; Shen CH; Chen PL; Chang D; Wang M
    Sci Rep; 2018 Feb; 8(1):2213. PubMed ID: 29396437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-guided JC polyomavirus-like particles specifically target bladder cancer cells for gene therapy.
    Lai WH; Fang CY; Chou MC; Lin MC; Shen CH; Chao CN; Jou YC; Chang D; Wang M
    Sci Rep; 2021 Jun; 11(1):11889. PubMed ID: 34088940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human lung adenocarcinoma growth and metastasis by JC polyomavirus-like particles packaged with an SP-B promoter-driven CD59-specific shRNA.
    Lin MC; Shen CH; Chang D; Wang M
    Clin Sci (Lond); 2019 Nov; 133(21):2159-2169. PubMed ID: 31693732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human bladder cancer growth by a suicide gene delivered by JC polyomavirus virus-like particles in a mouse model.
    Fang CY; Tsai YD; Lin MC; Wang M; Chen PL; Chao CN; Huang YL; Chang D; Shen CH
    J Urol; 2015 Jun; 193(6):2100-6. PubMed ID: 25623749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for castration-resistant prostate cancer cells using JC polyomavirus-like particles packaged with a PSA promoter driven-suicide gene.
    Lin MC; Wang M; Chou MC; Chao CN; Fang CY; Chen PL; Chang D; Shen CH
    Cancer Gene Ther; 2019 Jul; 26(7-8):208-215. PubMed ID: 30692600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of orthotopic castration-resistant prostate cancer growth and metastasis in mice by JC VLPs carrying a suicide gene driven by the PSA promoter.
    Chou CC; Tseng CE; Lin YS; Wang M; Chen PL; Chang D; Shen CH; Fang CY
    Cancer Gene Ther; 2024 Feb; 31(2):250-258. PubMed ID: 38072969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model.
    Chen LS; Wang M; Ou WC; Fung CY; Chen PL; Chang CF; Huang WS; Wang JY; Lin PY; Chang D
    Gene Ther; 2010 Aug; 17(8):1033-41. PubMed ID: 20410928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles.
    Lin MC; Wang M; Fang CY; Chen PL; Shen CH; Chang D
    Antiviral Res; 2014 Mar; 103():25-31. PubMed ID: 24406668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human JC virus-like particles as a gene delivery vector.
    Chang CF; Wang M; Ou WC; Chen PL; Shen CH; Lin PY; Fang CY; Chang D
    Expert Opin Biol Ther; 2011 Sep; 11(9):1169-75. PubMed ID: 21554145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles.
    Shen CH; Lin MC; Fang CY; Chen PL; Chou CC; Tung CL; Chao CN; Chang D; Wang M
    Gene Ther; 2023 Jun; 30(6):534-537. PubMed ID: 34285388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
    Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
    Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
    Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
    Costa LJ; Feldman AL; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Ansell SM
    Br J Haematol; 2008 Jul; 142(3):404-12. PubMed ID: 18492096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
    Hu WX; Zeng ZJ; Luo SQ; Chen Q
    Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma.
    Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A
    J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.